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Abstract. Various reasons lead to non-adherence to drug therapy, such as 
forgotten reordering of medications or wrong intake behavior. Blind and visually 
impaired persons face additional challenges, such as recognizing the medication 
package or reading the package insert which additionally impacts on patient safety. 
To address these challenges, we developed a concept for supporting medication 
management. In the center of the concept is the mobile application MyPills. It 
reminds on drug intake and reordering. These functionalities are made available to 
blind and visually impaired persons using screen reader functionalities. The 
current medication is entered into MyPills using the eMediplan, a Swiss national 
exchange format for eMedication. Beyond, package inserts are made accessible 
through voice output. MyPills supports in scanning the global trade item number 
(GTIN) for medication package identification. A usability tests carried out with six 
participants including two blind persons showed that users get along well with the 
app and the functionalities are helpful. In future studies with patients, it should be 
checked whether the MyPills app can improve compliance with drug therapy and 
impacts on intake behavior. 
Keywords. Medication management, mHealth, accessibility, medication 
adherence, mobile apps 
1. Introduction 
Several issues impact on patient safety and outcomes of drug treatments: overdosing, 
drug interactions, contraindications, or non-adherence (taking an incorrect dose, taking 
medication at the wrong time, or increasing or decreasing the frequency of doses 
without interacting with the prescribing physician) [1,2]. Reasons for non-adherence 
often include patients’ forgetfulness, inadequate knowledge, or lack of understanding 
of the consequences of poor compliance.  
There is a growing number of smartphone apps available to help people managing 
their medication [3]. Delivering self-management support digitally, including support 
for understanding and managing treatment, has shown improvements in health 
outcomes and processes of care for patients with chronic conditions [4]. However, most 
of the currently available apps only provide intake reminder functions, i.e. they follow 
a behavioral adherence strategy [5]. Re-fill reminder are rare and also medication 
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management apps that are accessible for blind and visually impaired persons are still 
missing. We could not identify such an app when searching in App stores.  
Therefore, we are focusing in this paper on the research question, how a mobile 
application can support blind and visually impaired persons in managing their 
medication or more specifically, which technologies and functionalities should be 
provided to facilitate medication management for this particular user group. We 
introduce a corresponding concept and implement it in the mobile application MyPills.  
2. Material and Methods 
2.1. Concept development  
In order to develop the concept for supporting the blind and visually impaired, an 
analysis was carried out, which consisted of three phases: First, the challenges in drug 
management for this particular user group were identified. We searched for literature in 
scientific databases (Pubmed, IEEE Xplore Digital Library, ACM Digital Library and 
Google Scholar). Further, we conducted an interview with the head of the Technology 
and Innovation Unit of the Swiss Federation of the Blind and Visually Impaired, with 
three pharmacists and one physician specialized in ophthalmology to collect existing 
challenges and problems with respect to medication management for patients. Beyond, 
we examined in a second phase the possibilities and recommendations described in the 
literature to help blind and visually impaired people managing their medication. In 
particular, guidelines from the American Foundation for the Blind for creating drug and 
medication management information suitable for blind and visually impaired were 
considered [6].  
Phase 1 and 2 resulted in challenges of blind and visually impaired in medication 
management. In a third phase, for each of these challenges three different variants of 
solutions were developed. We evaluated these variants according to feasibility and time 
factor. Finally, we used the best solution for each challenge to build our concept for 
medication management.   
2.2. App development 
Based on the concept developed to support blind and visually impaired people in their 
drug management, the requirements of the MyPills app were defined. The MyPills app 
was developed using Ionic (https://ionicframework.com). Ionic is a cross-platform 
mobile development technology. It allows to build applications for mobile devices and 
desktop computers using web technologies. Accessibility guidelines from W3C 
(https://www.w3.org/Translations/WCAG20-de/), iOS and Android were considered in 
app development [7,8].  
2.3. Usability test 
In order to assess the usability of the MyPills app, usability tests with two blind persons 
and four normal sighted persons (age between 30 and 70) were carried out. Normal 
sighted persons were involved since the application is expected to be useful for this 
user group as well. We recruited them from our personal context. For recruiting blind 
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persons, we contacted the Swiss Federation of the Blind and Visually Impaired. 
Unfortunately, only two persons were willing to join the test; people were either afraid 
or not interested in testing the application. We defined five scenarios that had to be 
addressed by the subjects using the app: 1) Test the application and find out about its 
functionalities, 2) Find out which medications you should take today at 6 pm, 3) Find 
out which medications have to be re-ordered, 4) You feel dizzy and have headaches; 
check whether these symptoms can be due to the intake of the medication Dafalgan 
(agent Paracetamol), and 5) You have two packages and want to find out which one is 
Dafalgan. The fifth scenario was only tested with blind persons.  
     The test persons received a smartphone with the pre-installed app from the test 
leaders. The initialization was carried out by the test leaders since our concept foresees 
later the support of the service provider in app initialization. The scenarios were read 
out by the test leaders. The test persons were not allowed to ask any questions and had 
to carry out the tasks independently without help. Unstructured interviews were 
conducted by two of the authors before and after the test. Pre-interviews collected 
information on the individual app usage. Post-interviews collected feedback on the 
usage experience and recommendations for improvement, including: 
 How do you like the structure of the MyPills App? 
 What do you particularly like or dislike in the app? 
 What was unclear to you? 
 Was the initialization process to get started with the MyPill App intuitive? 
 What benefits does the MyPills App offers to you? 
 What can be optimized? What is missing? What should be omitted? 
 Would you integrate the app into your everyday life? 
 Would you reorder your medication via the MyPills App? 
Further, the interaction with the app was monitored, but no help was given. The 
results were recorded in a Rainbow Spreadsheet.  
3. Results 
3.1. Results from literature search and interviews 
The literature review revealed that blind and visually impaired persons are confronted 
with additional challenges with respect to their medication management. These 
comprise correct dosing of medications, in particular of liquids, recognizing 
medications or distinguishing different packages and their shapes, reading and 
understanding package inserts with medication information or dosage instructions, 
recognizing expiration date, correct medication intake [9-11]. Furthermore, medication 
packages are often not equipped with descriptions in Braille, people cannot read Braille 
or other labels cover the Braille description [9-11]. Even though EU regulations (e.g. 
Directive 2001/83/EC, supplemented by 2004/27/EC) exist that make it mandatory to 
print the drug name in Braille on the package, these regulations are neither entirely 
implemented nor consistently monitored. Furthermore, it is impossible to place Braille 
on small packages and also difficult to ensure the readability [12].  One of the 
interview partners formulated an additional problem: The package insert is currently 
unavailable for blind persons. From these results, we derived four challenges to be 
addressed by our concept (Table 1).  
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 3.2. Solution variants for the identified challenges 
Table 1 shows for each of the four challenges the solution variants that we developed. 
The highlighted solutions were selected for our concept.  
 
Table 1: Variants for challenges. 1 = low effort, 2 = medium effort, 3 = high effort 
Variant Feasibility Time factor ∑ 
Challenge 1: Recognizing drugs and dosage information 
Label with dosage information in Braille or a font size 
legible for the blind or visually impaired 
3 2 5 
Label with simple marking, which is attached next to the 
GTIN and serves to locate the GTIN, so that it can be 
scanned with a smartphone application. No label with 
dosage information on the medication package. 
1 1 2 
Attaching other markings that allow distinguishing drug 
packages.  
1 1 2 
Challenge 2: Accessing package insert or intake instruction 
Package insert in Braille or a font size legible for the blind 
or visually impaired 
3 2 5 
Linking a website with patient information on drugs 1 2 3 
Smartphone application that provides direct access to patient 
information 
1 1 2 
Challenge 3: Recognizing expiry date 
Expiry date in Braille or a font size legible for the blind or 
visually impaired 
3 1 4 
Smartphone application that reminds on expiry date 2 1 3 
Reminding phone calls or SMS by health professionals or 
the healthcare team 
3 3 6 
Challenge 4: Reminder for drug intake 
Dosage boxes with integrated alarm functionality 2 2 4 
Smartphone application with reminder 1 1 2 
Reminding phone calls or SMS by health professionals or 
the healthcare team 
3 3 6 
3.3. Concept 
Our concept comprises three levels involving pharmaceutical companies, health 
professionals, and blind or visually impaired persons (Fig. 1). The MyPills app helps in 
identifying medication packages and provides information on a medication. For this 
purpose, a health professional places a marking next to the GTIN on the medication 
package, so that a blind or visually impaired person is made aware of the GTIN's 
location which can then be scanned by the MyPills app. The initial set up of the app, 
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i.e. scanning the QR code of the eMediplan to add the prescribed medication as 
background knowledge to the app, is also done by the health professional, for example 
by the pharmacist. Once this is done, the patient interacts with the app, receives 
reminder and information on the medication. The functionalities are described in more 
detail in the following. 
 
Figure 1. Concept underlying the MyPills app. In principle, legislation should monitor that accessibility 
guidelines are implemented in medication packages and that they are equipped with Braille. To bridge the 
gap, we suggest that health professionals put a marking on the drug package to indicate the location of the 
GTIN. All relevant medication information, dosage, intake and refill reminder will be provided by the 
MyPills app.  
 
3.4. MyPills app 
The MyPills app helps the blind or visually impaired in medication management. In 
particular, the following functionalities are provided:  
 Identification of medication package by scanning the GTIN on the medication 
package  
 Voice output of medication name and intake schema  
 Voice output of the package leaflet 
 
The MyPills app offers additional functionalities to help not only blind or visually 
impaired, but also normal sighted people to manage their medication. The QR code on 
the eMediplan, the Swiss national exchange format for eMedication, can be scanned. 
The corresponding medication and dosage information is automatically stored in the 
MyPills app. The QR code of the eMediplan can in turn be displayed which helps to 
transfer the current medication to another health professional. For long term 
prescriptions, the validity is stored and MyPills reminds when a renewal should be 
initiated. This allows the re-ordering of medications using the app.  
Medications to be taken on a current day are shown as prescribed and recorded in 
the eMediplan and corresponding intake reminders are provided by MyPills. Standard 
and even complex dosages are shown. Complex dosages include intake behavior when 
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stopping a drug – in these cases, the dosage has often to be reduced continuously. 
MyPills supports in this process. Other complex dosages include cyclic intake (e.g. take 
drug for 2 weeks, then stop for 2 weeks and continue afterwards). Even these intake 
schemas can be covered by the app, sending corresponding reminders. 
Based on the package size, the reserve on a particular drug is calculated and re-
ordering notifications are sent to the patient to avoid that he or she runs out of 
medications. The order can be released through the app when a specific pharmacy has 
been specified. The package insert can be accessed by a link to the Compendium 
(compendium.ch), a database that contains all drugs that are approved in Switzerland 
with corresponding information on contraindications etc.. Through screen reader 
functionalities, the package insert, intake schema or drug name can be read aloud. A 
health professional can be specified in the app to be contacted by E-Mail or telephone.  
4. Discussion and conclusions  
Three broad categories of adherence strategies, affective (targets adherence through 
appeals to feelings and emotions or social relationships), behavioral (targets adherence 
by targeting, shaping or reinforcing specific behavior patterns), and educational 
(targets adherence by conveying information) can be distinguished [3]. Park et al. [13] 
found out that the majority of medication adherence apps have features representing a 
behavioral approach to intervention. MyPills has the following features: tracking 
medication taking (behavioral); reminding to refill and indicating amount of 
medication left (behavioral); storing medication information (educational); providing 
complex medication instructions or notes; database of medications (educational).  
4.1. Usability test results and research question 
The test results showed that the test persons immediately understood the MyPills App 
and its functionalities and considered app and concept very useful. The app was 
perceived as clear and understandable. The blind people found the scanning of the drug 
package very helpful and would prefer if the camera has a larger scatter so that 
scanning is facilitated. All test persons would use the MyPills App in everyday life. 
They considered the online link to the package insert and the voice output of the 
package insert very helpful. Overall, the concept for supporting the blind and visually 
impaired with the MyPills app is a viable way to support the medication management 
of the blind and visually impaired. Nevertheless, it should be mentioned that only two 
blind test subjects could be recruited for the usability tests. Further usability tests have 
to be carried out to ensure the usability of the application.  
The main research question in this work was how a mobile application can support 
blind and visually impaired persons in managing their medication. The MyPills app 
helps the blind or visually impaired to identify the medication by reading the GTIN on 
the medication package and reading the medication name and other information about 
the medication. We found out that screen reader functionalities can be used to provide 
access to the package insert and help in interacting with the app. In future, information 
retrieval functionalities could be integrated to allow specific questions instead of 
reading the entire package insert at once (e.g. the question “what are the 
contraindications?” could be posed and the corresponding paragraph will be read 
aloud).  
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Stawarz et al. suggest that also complex intake schemas should be supported by 
medication management applications [14]. In MyPills, we specifically integrated 
complex dosages and intake schemas. In summary, the MyPills app provides 
functionalities to reduce the risk of incorrect intake. In future studies with patients, it 
has to be checked whether the MyPills app can actually improve adherence and 
compliance with therapy and how it impacts on medication safety. 
4.2. Accessibility 
Switzerland has set up an eCH specialist group "Accessibility" and developed the "eCH 
Standard 0059". These instruments are intended to make the necessary information and 
services available to public authorities and other providers. In this way, the services 
offered on the Internet can be implemented according to uniform criteria. A practice-
oriented checklist has been made available so that the technical implementation and 
review of the WCAG-2.0 requirements and eCH standard can be reviewed. These 
documents are publicly available on the www.ch.ch/accessibility website. We tested 
the MyPills App with the checklist. In summary, it can be said that the MyPills App 
has fully met compliance categories A and AA and is therefore a barrier-free app. 
4.3. Practical implications 
Our concept foresees to integrate a health professional into the process of app 
installation or marking of drug packages. In order to keep the effort as low as possible, 
the approach was chosen that only a simple marking, not related to a specific 
medication, is attached to the drug package next to the GTIN, so that the blind or 
visually impaired person is made aware of the localization of the GTIN. The usability 
tests have shown that it was easy to recognize the marking, but the blind and visually 
impaired prefer a mark that also indicates the direction in which the barcode is located, 
such as an arrow symbol. We have used simple round markers for our usability tests. 
As a result, the blind were unsure whether the GTIN was to the right or left of the 
marking. Another option would be to have 2 markings indicating two borders of the 
GTIN. Furthermore, the test revealed that the MyPills app must provide more precise 
information about the distance between the smartphone and the medicine package in 
order to enable optimal and rapid scanning of the GTIN.  
 We asked in our interviews how much time health professionals could invest in 
the explanation of the app and marking of drug packages. The pharmacist and the 
physician claimed that 10-15 minutes per patient would be realistic. Thus, our concept 
could be well realized in practice. However, it is recommendable that all medication 
packages are enriched with accessible information right from the production to help the 
blind and visually impaired recognizing the package. In addition, the inscription of the 
medication should be made in the font size specified in accessibility guidelines [6,15] 
and color blindness should also be taken into account when selecting colors for 
designing dosage instructions [9]. How many drugs in Switzerland actually bear Braille 
and whether the pharmaceutical companies comply with the accessibility guidelines 
was not examined in detail in the context of this work. Since 2019, drug packages are 
equipped with a 2D data matrix for more security and safety against forgery. Wesch 
suggests to store additional information in these data matrixes [12] and to use mobile 
applications to retrieve this information [12]. The information could be even made 
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available in different languages. The MyPills app could be well used to read the data 
matrix information.  
The reordering functionality has already been implemented. Of course, it is only 
possible to reorder medications where a long term prescription is available. The app 
stores the validity of the prescriptions and also reminds when the validity ends. A 
pharmacy has to implement a digital reordering process to make use of this 
functionality. The concept has to be evaluated in cooperation with health professionals 
in pharmacies and doctors' practices in order to clarify its implementation in practice 
more precisely. 
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